Catherine Akers

Currently Regulatory Affairs Manager at Amgen, UK, Catherine Akers began her career as a clinical research associate, monitoring the conduct of clinical trials and visiting doctors responsible for trialling new drugs. “The collection of safety events for subjects is key in any clinical trial but that is only the tip of the iceberg,” says Catherine. “The continued collection of safety information once a medicine is in use ensures that benefits and risks can be carefully assessed throughout a product’s lifecycle.” As the safety of drugs continues to make newspaper headlines, Catherine believes that more measures to monitor the safety of medicines can only be a good thing. And that is where she is today; using her knowledge of drug development and current legislation to advocate for increasingly robust practices for the collection of safety events.